Evaluation of the Efficiency of the PRPP (Perceive, Recall, Plan and Perform) Task Analysis System on Support and Orientation Decisions for People With Aging Psychiatric Disorders (PATPV) Living in Independent Housing. (ECO2PSY)

Over the past 30 years, mental health policy has been geared towards increasing the number of people receiving care in the community, with a reduction of over 50% in the number of general psychiatric beds. The WHO recommends the implementation of alternatives to hospitalization, through the development of outpatient and home-based psychiatric care programs that support independent living.

People suffering from psychiatric disorders show cognitive decline as they age, including deficits in perception, attention, memory and problem-solving. These cognitive problems affect the ability to carry out the tasks of daily life, and make it more difficult to remain at home. In order to avoid hospitalization for these psychiatrically-stabilized patients who are losing their autonomy, it is necessary to take into account their mental and cognitive handicap, and to provide them with appropriate compensation.

Occupational therapy is a discipline concerned with the assessment, rehabilitation and integration of people with disabilities. Occupational therapists provide ecological assessments to support personalized care plans. The PRPP (Perceive, Recall, Plan and Perform) task analysis system is a validated, ecological tool that integrates an occupational therapy assessment and intervention model. The PRPP assessment measures occupational performance and the impact of cognitive impairments on information processing and on the cognitive strategies required to carry out activities. Research conducted in Canada illustrates the value of PRPP in supporting people with schizophrenia. To the best of our knowledge, no team has studied the use of PRPP in the decision-making process for maintaining people with aging psychiatric disorders (PATPV) at home.

Study Overview

Detailed Description

The main hypothesis is that the use of the PRPP, through its scientific validity, will facilitate the decision-making of multi-professional care teams for the ambulatory support of PATPV to support :

  • maintenance of independent housing
  • or referral to a suitable place to live

This is a prospective, single-center study conducted within the "pathologies, handicap and aging" unit of the General and University Psychiatry (PGU) cluster at the Charles Perrens Hospital in Bordeaux.

The "pathologies, disability and aging" unit is dedicated to addressing the loss of autonomy and disability of people suffering from severe psychiatric disorders. One of its aims is to prevent hospitalization, particularly long-term hospitalization, for patients with chronic psychiatric pathologies who have become care-dependent. The program is structured around a multi-professional mobile team in charge of assessments, and a day hospital providing outpatient psychosocial rehabilitation care.

Study Type

Interventional

Enrollment (Estimated)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Gironde
      • Bourdeaux, Gironde, France, 33076
        • Recruiting
        • Centre Hospitalier Charles Perrens
        • Contact:
        • Contact:
        • Principal Investigator:
          • Julie BONVALLET

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Be at least 40 years old
  • Reside within the PGU sector (Mérignac, Pessac, Talence and Gradignan)
  • Receive support from the PGU - CHCP "pathologies, disability and aging" department.
  • Fluency in French

Exclusion Criteria:

  • Being hospitalized for more than 18 months
  • Refuse inclusion in the research project

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PRPP Evaluation

T0 to T3 months: Evaluations

  • Multi-professional assessment by mobile team or day hospital
  • Completion of PRPP on 2 activities

T3 months: First referral

- Decision on the participant's future orientation following the PRPP

T3 months to T9 months: Outpatient psychosocial rehabilitation (standard care)

  • Personalized psychosocial rehabilitation program determined in part by the PRPP and carried out in the day hospital for all participants.
  • PRPP interventions (occupational therapy)

T9 months: Reassessment and confirmation of orientation

  • Second round of PRPP based on activities assessed at T3 months
  • Questionnaires to help with referral decisions, completed by the multi-professional teams involved in the program, and by the treating psychiatrist after the second PRPP has been completed.
Passing the PRPP for 2 activities

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficiency of the PRPP system for living orientation
Time Frame: 9 months after inclusion
Scoring the PRPP system for monitoring changes in occupational performance following the implementation of a personalized psycho-social rehabilitation project.
9 months after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of hospitalizations since inclusion
Time Frame: 12 months after inclusion
Counting the number of hospitalizations
12 months after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

December 9, 2024

First Submitted That Met QC Criteria

December 13, 2024

First Posted (Actual)

December 18, 2024

Study Record Updates

Last Update Posted (Actual)

March 16, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mental Health

Clinical Trials on Perceive, Recall, Plan and Perform (PRPP) evaluation

Subscribe